Visby Engages Quest and Labcorp to Broaden Consumer Access to First At-Home, FDA-Authorized PCR Test for STIs
Today, Visby Medical announced two new relationships that will expand national access to the Visby Women’s Sexual Health Test, the first, at-home, FDA-authorized PCR test for sexually transmitted infections (STIs) available to consumers, enabling immediate access to Visby’s integrated "Test-to-Treat" ecosystem. The palm-sized device delivers confidential results in just 30 minutes, providing women with a rapid response for chlamydia, gonorrhea, and trichomoniasis from the comfort and privacy of the home.
Visby Medical Tackles STI Epidemic with First At-Home FDA-Authorized PCR Test in Partnership with Google Cloud
Visby Medical today announced the national launch of the first-of-its-kind FDA-authorized at-home PCR test for sexually transmitted infections (STIs) in women, redefining how sexual health is diagnosed and treated. The palm-sized test, now available nationwide with seamless virtual care support and rapid home delivery, accurately detects three of the most common and often asymptomatic infections—chlamydia, gonorrhea, and trichomoniasis—in just 30 minutes.
